Omeprazole and rabeprazole are two medications that belong to a class of drugs known as proton pump inhibitors (PPIs). These medications are widely used to treat various gastrointestinal disorders, primarily by reducing the production of stomach acid. For many individuals suffering from conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, or Zollinger-Ellison syndrome, PPIs provide significant relief by alleviating symptoms and promoting healing of the esophagus and stomach lining. Despite their similarities in action, omeprazole and rabeprazole have distinct characteristics that may influence a physician’s decision when prescribing these medications. Factors such as efficacy, side effects, drug interactions, and patient-specific considerations can all play a role in determining which…